Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) has earned a consensus rating of "Hold" from the six analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $17.17.
Several analysts have recently commented on HR shares. Scotiabank upped their price objective on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the company a "sector perform" rating in a report on Wednesday, August 7th. Wedbush upped their price target on shares of Healthcare Realty Trust from $15.00 to $18.00 and gave the company a "neutral" rating in a report on Monday, August 5th. Finally, Wells Fargo & Company reiterated an "underweight" rating and set a $17.00 price objective (up previously from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st.
Read Our Latest Stock Analysis on Healthcare Realty Trust
Insiders Place Their Bets
In other Healthcare Realty Trust news, Director John Knox Singleton purchased 6,500 shares of the stock in a transaction on Thursday, September 5th. The shares were bought at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the transaction, the director now owns 57,082 shares of the company's stock, valued at $1,041,175.68. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, Director John Knox Singleton acquired 6,500 shares of Healthcare Realty Trust stock in a transaction on Thursday, September 5th. The stock was bought at an average cost of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the transaction, the director now owns 57,082 shares of the company's stock, valued at approximately $1,041,175.68. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Thomas N. Bohjalian bought 9,000 shares of the company's stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $17.39 per share, for a total transaction of $156,510.00. Following the transaction, the director now owns 22,252 shares of the company's stock, valued at approximately $386,962.28. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 15,728 shares of company stock worth $279,069. Company insiders own 0.56% of the company's stock.
Institutional Investors Weigh In On Healthcare Realty Trust
Several large investors have recently bought and sold shares of the company. Canada Pension Plan Investment Board boosted its position in Healthcare Realty Trust by 52.3% during the first quarter. Canada Pension Plan Investment Board now owns 10,942,261 shares of the real estate investment trust's stock worth $154,833,000 after acquiring an additional 3,758,040 shares during the last quarter. Pzena Investment Management LLC acquired a new position in shares of Healthcare Realty Trust during the 3rd quarter worth approximately $40,392,000. Vanguard Group Inc. boosted its holdings in shares of Healthcare Realty Trust by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 54,246,277 shares of the real estate investment trust's stock worth $767,585,000 after purchasing an additional 723,197 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Healthcare Realty Trust in the second quarter valued at approximately $10,304,000. Finally, Candriam S.C.A. acquired a new stake in shares of Healthcare Realty Trust in the second quarter valued at approximately $8,911,000.
Healthcare Realty Trust Stock Performance
HR stock traded up $0.23 during midday trading on Friday, reaching $17.78. The stock had a trading volume of 2,876,025 shares, compared to its average volume of 2,899,955. The firm has a fifty day simple moving average of $17.85 and a two-hundred day simple moving average of $17.05. Healthcare Realty Trust has a 52-week low of $12.77 and a 52-week high of $18.90. The stock has a market cap of $6.30 billion, a PE ratio of -11.25 and a beta of 0.91.
Healthcare Realty Trust Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Tuesday, November 12th will be issued a $0.31 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a yield of 6.97%. Healthcare Realty Trust's payout ratio is -78.48%.
About Healthcare Realty Trust
(
Get Free ReportHealthcare Realty NYSE: HR is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Featured Stories
Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.